Fundraising Fox
Congruence Therapeutics
Founded 2021 · 43 employees on LinkedIn · 8 known investors
Find your way into Congruence Therapeutics
Sign up to see every warm intro you have to Congruence Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Congruence Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Congruence is a drug discovery company that applies protein dynamics, biophysics, machine learning, and computational chemistry to model proteins in their full dynamic state and predict disease correction in silico. It uses these computational methods to identify and design therapeutics.
Founders & leadership
Congruence Therapeutics was founded in 2021 by Clarissa Desjardins.
Investors · 8
How we know: OrbiMed's portfolio page · the company's own site · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: BDC Thrive Venture Fund for Women's portfolio page · Not right? Tell us
How we know: Lumira Ventures's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Related companies · 1
Companies working in the same space as Congruence Therapeutics.
Frequently asked questions
- What does Congruence Therapeutics do?
- Congruence is a drug discovery company that applies protein dynamics, biophysics, machine learning, and computational chemistry to model proteins in their full dynamic state and predict disease correction in silico. It uses these computational methods to identify and design therapeutics.
- Who founded Congruence Therapeutics?
- Congruence Therapeutics was founded by Clarissa Desjardins in 2021.
- Who are Congruence Therapeutics's investors?
- Congruence Therapeutics's investors include OrbiMed, Alexandria, DIMENSION, Angelini Ventures, BDC Thrive Venture Fund for Women, Lumira Ventures, Amplitude Venture Capital, Dimension Capital.